Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01776723 · OUTCOME

Median Overall Survival (OS)

A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib · Source last updated 2022-09-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
months
Interval / dispersion
95% Confidence Interval
Time frame
Up to 2 years

What was measured

Phase II - To determine the median overall survival.

Analysis population: All participants who received ruxolitinib therapy

Groups in this outcome

II: Maximum Tolerated Dose - Ruxolitinib

Phase II: Treatment at Maximum Tolerated Dose (MTD).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
II: Maximum Tolerated Dose - Ruxolitinib30

Reported measurements

Source class 1
Values in months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
II: Maximum Tolerated Dose - Ruxolitinib23.7Not reported13.330Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        13.3
        upper Limit
        30
        value
        23.7
denoms
  1. counts
    1. group Id
      OG000
      value
      30
    units
    Participants
description
Phase II - To determine the median overall survival.
dispersion Type
95% Confidence Interval
groups
  1. description
    Phase II: Treatment at Maximum Tolerated Dose (MTD).
    id
    OG000
    title
    II: Maximum Tolerated Dose - Ruxolitinib
param Type
MEDIAN
population Description
All participants who received ruxolitinib therapy
reporting Status
POSTED
time Frame
Up to 2 years
title
Median Overall Survival (OS)
type
SECONDARY
unit Of Measure
months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice